Patents by Inventor Alain Laroze

Alain Laroze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 9051281
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: June 9, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet
  • COMPOUNDS
    Publication number: 20130281499
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: June 21, 2013
    Publication date: October 24, 2013
    Inventors: Anne Marie Jeanne BOUILLOT, Alain Laroze, Lionel Trottet
  • 1,2,3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors
    Patent number: 8486977
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: July 16, 2013
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet
  • COMPOUNDS
    Publication number: 20120225878
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for inhibiting SCD activity.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 6, 2012
    Inventors: Anne Marie Jeanne BOUILLOT, Alain LAROZE
  • Triazole derivatives as SCD inhibitors
    Patent number: 8207204
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for inhibiting SCD activity, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming A?42 peptide such as Alzheimer's disease and the like.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: June 26, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze
  • COMPOUNDS
    Publication number: 20100297097
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for inhibiting SCD activity, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming A?42 peptide such as Alzheimer's disease and the like.
    Type: Application
    Filed: November 7, 2008
    Publication date: November 25, 2010
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze
  • 1,2,3-TRIAZOLE DERIVATIVES FOR USE AS STEAROYL-COA DESATURASE INHIBITORS
    Publication number: 20100297054
    Abstract: The present invention relates to substituted triazole compounds of the formula (I): and pharmaceutically acceptable salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds for modulating SCD activity.
    Type: Application
    Filed: November 7, 2008
    Publication date: November 25, 2010
    Inventors: Anne Marie Jeanne Bouillot, Alain Laroze, Lionel Trottet